Sinovac Biotech Ltd. (SVA)

7.70
0.04 0.52
NASDAQ : Health Technology
Prev Close 7.66
Open 7.60
Day Low/High 7.60 / 7.70
52 Wk Low/High 6.50 / 8.75
Volume 3.06K
Avg Volume 40.00K
Exchange NASDAQ
Shares Outstanding 59.32M
Market Cap 456.77M
EPS 0.50
P/E Ratio 17.11
Div & Yield N.A. (N.A)

Latest News

SVA Makes Notable Cross Below Critical Moving Average

SVA Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of Sinovac Biotech Ltd crossed below their 200 day moving average of $7.75, changing hands as low as $7.73 per share. Sinovac Biotech Ltd shares are currently trading down about 1.6% on the day.

Sinovac Biotech Relaunches Company Website

Sinovac Biotech Relaunches Company Website

BEIJING, June 11, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:  SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the company has relaunched its website, at www.

Sernova's Cell Pouch Regenerative Medicine Clinical Trial For Patients With Type 1 Diabetes Supported With Continuous Glucose Monitoring Systems

Sernova's Cell Pouch Regenerative Medicine Clinical Trial For Patients With Type 1 Diabetes Supported With Continuous Glucose Monitoring Systems

Continuous Glucose Monitoring System (CGM) to provide sensitive tracking of key efficacy measures in patients at important time points throughout the study

First Week of July 2018 Options Trading For Sinovac Biotech (SVA)

First Week of July 2018 Options Trading For Sinovac Biotech (SVA)

Investors in Sinovac Biotech Ltd saw new options begin trading this week, for the July 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

September 1st Deadline Alert: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Sinovac Biotech Ltd.

September 1st Deadline Alert: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Sinovac Biotech Ltd.

Law Offices of Howard G. Smith reminds investors of the September 1, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Sinovac Biotech Ltd.

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Sinovac Biotech Ltd. Shareholders And A Lead Plaintiff Deadline Of September 1, 2017

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Sinovac Biotech Ltd. Shareholders And A Lead Plaintiff Deadline Of September 1, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sinovac Biotech Ltd.

The Klein Law Firm Announces A Class Action Filed On Behalf Of Sinovac Biotech Ltd. Shareholders And A Lead Plaintiff Deadline Of September 1, 2017

The Klein Law Firm Announces A Class Action Filed On Behalf Of Sinovac Biotech Ltd. Shareholders And A Lead Plaintiff Deadline Of September 1, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sinovac Biotech Ltd.

SVA INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Sinovac Biotech Ltd. And A Lead Plaintiff Deadline Of September 1, 2017

SVA INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Sinovac Biotech Ltd. And A Lead Plaintiff Deadline Of September 1, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in District of New Jersey on behalf of investors who purchased Sinovac Biotech Ltd.

SVA SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Sinovac Biotech Ltd. And A Lead Plaintiff Deadline Of September 1, 2017

SVA SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Sinovac Biotech Ltd. And A Lead Plaintiff Deadline Of September 1, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in District of New Jersey on behalf of investors who purchased Sinovac Biotech Ltd.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Sinovac Biotech Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 1, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Sinovac Biotech Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 1, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sinovac Biotech Ltd.